Collision-induced dissociation of valdecoxib metabolites: a novel rearrangement involving an isoxazole ring

J Mass Spectrom. 2004 Mar;39(3):295-302. doi: 10.1002/jms.582.

Abstract

Valdecoxib is a potent COX-2 inhibitor. During metabolism studies of valdecoxib by liquid chromatography/tandem mass spectrometry, we observed a novel mass spectral rearrangement involving an isoxazole ring for some of the metabolites in the negative ion mode. Accurate mass measurements were performed with quadrupole time-of-flight mass spectrometry to determine the elemental compositions of the fragments. Additionally, two types of stable-isotope labeled analogues were prepared to assist with the assignments of these fragments and possible mechanistic rearrangements resulting from collision-induced dissociation (CID). Detailed analyses of the CID mass spectra suggest that the fragmentation process involves a novel two-step rearrangement. The first step consists of an intramolecular SN2 reaction with a five-membered ring rearrangement to form an intermediate. The second step involves a four-membered ring intramolecular rearrangement followed by a cleavage of the N-O bond on the isoxazole ring to form a unique fragment ion at m/z 196. The same phenomenon was observed for a group of structurally related metabolites that also contain a 5-hydroxymethyl or 5-carboxylic acid moieties. A mechanism for the novel rearrangement involving an isoxazole ring is proposed.

MeSH terms

  • Animals
  • Chromatography, Liquid / methods*
  • Cyclooxygenase Inhibitors / analysis
  • Cyclooxygenase Inhibitors / chemistry
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Humans
  • Isoxazoles / analysis*
  • Isoxazoles / chemistry*
  • Isoxazoles / pharmacokinetics*
  • Mass Spectrometry / methods*
  • Sulfonamides / analysis*
  • Sulfonamides / chemistry
  • Sulfonamides / pharmacokinetics*

Substances

  • Cyclooxygenase Inhibitors
  • Isoxazoles
  • Sulfonamides
  • valdecoxib